Edmund Ingham, Investing Group leader behind the Haggerston BioHealth service, says savvy investors should consider biotech companies of all sizes for a diversified portfolio. Adding dividend ...
Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing ...
Copyright 2025 The Associated Press. All Rights Reserved. Venezuela’s Edmundo Gonzalez Urrutia thanks parliament members after delivering his speech as he and ...
The internal announcement comes after the senior M&A partner was linked to a breakaway firm being funded by private equity. He will depart by the end of June.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback